203 related articles for article (PubMed ID: 35056092)
1. Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents.
Lagardère P; Fersing C; Masurier N; Lisowski V
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056092
[TBL] [Abstract][Full Text] [Related]
2. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
3. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates.
Islam F; Quadery TM
Curr Drug Targets; 2021; 22(17):1944-1963. PubMed ID: 34042033
[TBL] [Abstract][Full Text] [Related]
5. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of substituted thieno[2,3-d]pyrimidine-2,4-dithiones and their S-glycoside analogues as potential antiviral and antibacterial agents.
Hafez HN; Hussein HA; El-Gazzar AR
Eur J Med Chem; 2010 Sep; 45(9):4026-34. PubMed ID: 20691339
[TBL] [Abstract][Full Text] [Related]
7. Extended structure-activity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties.
Bugge S; Buene AF; Jurisch-Yaksi N; Moen IU; Skjønsfjell EM; Sundby E; Hoff BH
Eur J Med Chem; 2016 Jan; 107():255-74. PubMed ID: 26599532
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antimicrobial activity of new substituted thienopyrimidines, their tetrazolyl and sugar derivatives.
El-Sayed WA; Ali OM; Zyada RA; Mohamed AA; Abdel-Rahman AA
Acta Pol Pharm; 2012; 69(3):439-47. PubMed ID: 22594258
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of Antimicrobial Activity and Molecular Dock - ing of New N-1,3-thiazol-2-ylacetamides of Condensed Pyrido[3',2':4,5] furo(thieno)[3,2-d]pyrimidines.
Sirakanyan SN; Kartsev VG; Geronikaki A; Spinelli D; Petrou A; Hakobyan EK; Glamoclija J; Ivanov M; Sokovic M; Hovakimyan AA
Curr Top Med Chem; 2020; 20(24):2192-2209. PubMed ID: 32598259
[TBL] [Abstract][Full Text] [Related]
10. Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors.
Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; Lee J
Bioorg Med Chem Lett; 2014 Dec; 24(23):5473-7. PubMed ID: 25455487
[TBL] [Abstract][Full Text] [Related]
11. Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities.
Ghith A; Ismail NSM; Youssef K; Abouzid KAM
Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 29027246
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor.
Bugge S; Kaspersen SJ; Larsen S; Nonstad U; Bjørkøy G; Sundby E; Hoff BH
Eur J Med Chem; 2014 Mar; 75():354-74. PubMed ID: 24556149
[TBL] [Abstract][Full Text] [Related]
13. THE STIMULATING EFFECT OF THIENOPYRIMIDINES, THE STRUCTURAL ANALOGS OF ORG 43553, ON THE ACTIVITY OF ADENYLYL CYCLASE IN THE TESTES AND ON THE TESTOSTERONE PRODUCTION IN MALE RATS.
Derkach KV; Legkodukh AS; Dar’in DV; Shpakov AO
Tsitologiia; 2016; 58(8):602-9. PubMed ID: 30183200
[TBL] [Abstract][Full Text] [Related]
14. Thiazolo[4,5-d]pyrimidines as a privileged scaffold in drug discovery.
Kuppast B; Fahmy H
Eur J Med Chem; 2016 May; 113():198-213. PubMed ID: 26942627
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Activity Evaluation of New Thieno[2,3-
Shyyka O; Pokhodylo N; Finiuk N; Matiychuk V; Stoika R; Obushak M
Sci Pharm; 2018 Jul; 86(3):. PubMed ID: 30012942
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antibacterial activity of novel pleuromutilin derivatives with thieno[2,3-d]pyrimidine substitution.
Ding R; Wang X; Fu J; Chang Y; Li Y; Liu Y; Liu Y; Ma J; Hu J
Eur J Med Chem; 2022 Jul; 237():114398. PubMed ID: 35468515
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of thiophene and N-substituted thieno[3,2-d] pyrimidine derivatives as potent antitumor and antibacterial agents.
Hafez HN; Alsalamah SA; El-Gazzar ABA
Acta Pharm; 2017 Sep; 67(3):275-292. PubMed ID: 28858838
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents.
Liu Z; Wu S; Wang Y; Li R; Wang J; Wang L; Zhao Y; Gong P
Eur J Med Chem; 2014 Nov; 87():782-93. PubMed ID: 25440879
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis of thieno(3,3-d)- and -(3,4-d)pyrimidines by alternative ring closure reactions].
Briel D; Maschke T; Wagner G
Pharmazie; 1992 Aug; 47(8):577-9. PubMed ID: 1438509
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimicrobial activity of new amino derivatives of pyrano[4'',3'':4',5']pyrido[3',2':4,5]thieno[3,2-d]pyrimidine.
Sirakanyan SN; Geronikaki A; Spinelli D; Hakobyan EK; Kartsev VG; Petrou A; Hovakimyan AA
An Acad Bras Cienc; 2018; 90(1 Suppl 2):1043-1057. PubMed ID: 29694500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
